Articles from Instrument Business Outlook (July 31, 2006)

Title	Author	Type	Words
A new report from the National Academies' National Research Council, Controlling the Quantum World, argues that the United States should increase its funding for atomic, molecular and optical (AMO) science.		Brief article	145
According to a report by Andrew G. Maynard, chief science officer of the Project on Emerging Nanotechnologies, as little as $11 million of the $1 billion the government invests every year in nanotechnology goes to highly relevant research on the risks of nanotechnology.			207
According to Chemical and Engineering News' latest rankings of chemical companies, Dow Chemical was the leader, with chemical sales of $46.3 billion- Coming in second was BASF, with a sales figure of $43.7 billion Royal Dutch/Shell was third at $35.0 billion, and Exxon Mobil was fourth at $31.2 billion.			187
Advanced Chemistry Developments.			22
Advanced Chemistry Developments.			25
Affibody AB.			14
Affymetrix.			52
Agilent and Ingenuity Systems are establishing integration between their respective GeneSpring Analysis platform for statistical analysis.			24
Agilent appointed Paul N. Clark to its board in May.			22
Agilent's GeneSpring software is now compatible.			10
Agilent.			26
Alfa Wasserman Proteomic Technologies.			35
Analytik Jena AG.			11
Ariadne Genomics joined Affymetrix's GeneChip.			7
Beckman Coulter.			36
Bio-Rad and Integrated DNA Technology are collaborating to develop validated siRNA duplexes.			21
Biomax Informatics AG.			11
Bruker AXS enters portable XRF market.		Brief article	152
CambrigeSoft and Schrodinger introduced Chem3D with Jaguar for Windows.			22
Carl Zeiss acquires microscope company.		Brief article	135
Chinese contract manufacturing organizations (CMOs) are increasing in number. Nearly half of China's pharmaceutical factories are not being used, and factory owners are taking advantage of this unused capacity.			207
CombiMatrix entered into a distribution and manufacturing agreement with Prisma Biotech.			22
CombiMatrix released the next generation CustomArray Synthesizer.			11
CombiMatrix.			6
CyBio AG acquires majority share of customized automation company.			102
Cytori Therapeutics, Cambrex Bio Science.			22
DiscoveRx released PathHunter.			6
DiscoveRx.			11
Enzo Biochem appointed Carl W. Balezentis, Ph.D., to the newly created position of president of Enzo Life Sciences.			25
Eppendorf AG.			11
Eppendorf released the TF Chip human MAPK (mitogen-activated protein kinases) kit.			18
Eppendorf.			7
Eurogentec SA licensed Oxford Gene Technology's Southern.			9
Genedata.			8
GeneGo and XB TransMedSolutions integrated their respective MetaCore software and XB-BioIntegration Suite for the capture.			25
GL Biochem.			11
Harvard Bioscience.			21
IBO stock indexes lose ground in July.			3578
Illumina launched the Illumina Autoloader and software.			13
In April, CombiMatrix formed CombiMatrix Europe GmbH.			11
In April, ExonHit Therapeutics introduced its SpliceArrays for GPCR, ion channel.			20
In july, Agilent appointed Nick Roelofs, Ph.D., vice president and general manager of the Life Sciences Solutions Unit.			31
In July, Canadian consulting and contract manufacturing company PharmaEng International acquired Rootlink Technic.			27
In June, Affymetrix granted Epigenomics AG access to technology.			16
In June, CombiMatrix Molecular Diagnostics and Alpha Innotech.			20
In June, Waters announced collaborations with the China Municipal Center for Disease Prevention and Control.			47
In May, Agilent and ExonHit expanded their alliance to enable Agilent to market and sell.			22
In May, Media Cybernetics, a provider of scientific image analysis software.			29
Indigo BioSystems.			16
InforSense.			9
Insilicos introduced Proteomics Pipeline.			23
Invitrogen and Cellartis AB are developing novel-engineered human embryonic stem cell.			27
Invitrogen entered into a scientific collaboration with the Human Proteome Organization focused on education initiatives.			25
Invitrogen licensed Geron's intellectual property.			14
Jivan Biologics.			11
Macrogen will manufacture and distribute arrays in Korea .			11
Magellan Biosciences named Michael E. Woehler, Ph.D., to its board.			17
Market profile: superconducting magnets.			478
Mid-year forecast review: prospects brighten.			1189
Neogen.			21
Olympus buys Evotec's single molecule detection technology.			123
Oxford Instruments.			22
PerkinElmer appointed Dr. Daniel R. Marshak vice president and chief scientific officer.			28
PerkinElmer grows prenatal screening business.			171
QIAGEN and CytoPathfinder formed a strategic partnership to develop high-throughput RNAi screening tools.			23
Rosetta Biosoftware and Sage-N Research are establishing interoperability between their respective Elucidator system.			22
Rosetta Biosoftware.			15
Seiko Instruments.			26
Sigma-Aldrich exclusively licensed Rosetta Inpharmatics.			10
Sigma-Aldrich.			12
Sirna Therapeutical.			38
Spain's two largest oil producers are making large investments in the biofuels industry.			202
Spotfire and BioImagene integrated their respective DecisionSite.			11
Symyx Technologies.			7
Systat Software.			35
Techcomp.			11
The bottom line: data from recent industry financial reports. Dollar amounts in millions.		Statistical table	447
The French government announced in July that it would allocate 80 million [euro] ($102 million) to support 68 R&D projects.		Brief article	105
The NIH named Pierce Biotechnology, a Fisher Biosciences company.			26
Thermo consolidates position in isotope ratio MS market.			130
Thermo Electron appointed Adept Scientific to supply and support its Kinetica pharmacokinetic-pharmacodynamic applications in the UK.			21
Thermo Electron.		Brief article	60
Three perspectives on the R&D challenge.			2864
Under a research agreement.			16